Face-to-Face requirements: all participants planning to travel to Berlin for a face-to-face event are required to present a daily negative COVID-19 test OR need to prove a full course of the COVID-19 vaccine. A second dose must be administered at least 14 days prior to your travel to the PharmaSynergy.
The event is built around 1-2-1 meetings that connect global pharma BD & Licensing professionals together, empowered further by the content-driven programme. Whether you join us to understand where the generics industry is heading, to learn about BD opportunities in #pharmerging and #mature markets or to arrange for the #partnering_meetings with new and established BD peers – #PharmaSynergy is your go-to event for #Business_Development & Licensing.
Product portfolio focus: Generics, niche, branded and OTC, CHC
- Considering the short- and long-term impacts on the pharmaceutical market and licensing environment, what are therapeutic categories in prescription, branded, generic & OTC products showing the most growth potential? What effect does the current environment have on non-covid products' performance?
- New! With the rise of digital solutions - what opportunities are presented to pharma companies along the value chain?
- New! Spotlight: Exploring medical cannabis market landscape and opportunities
- Geo opportunities and go-to-market strategies: post-pandemics shifts and opportunities
Here's a little preview of the programme ahead:
"The current opportunities in consumer health and OTC products for the Latin American market" by Helio Marcelo Segouras, Consumer Health Division Head, #Hypera_Pharmaceutical
"Assessing the pandemic’s impact on companies’ portfolios and BD&L strategies" by Fabian Riess, Senior Director Business Development & Strategy, Consumer Selfcare International, #Perrigo
"The internationalization from the perspective of a B2B focused company" - João Ribeiro, Head of Medical Business, #Chanelle_Pharma
"The cannabis market: an overview of the key regulatory developments and opportunities in Europe" - Franziska Katterbach, Managing Director & Chief Legal Officer, Europe #Khiron_Life_Sciences
What to expect from 1-2-1 partnering?
Building upon the success of five consecutive editions (live & virtual), #PharmaSynergy is a global partnering event for dynamic pharma with value-added/niche generics & OTC portfolios. The event offers an intensive content-driven programme and pre-arranged partnering meetings.
With 15% of CEOs / Managing Directors, 47% of Senior Vice Presidents / Heads of Business Development, and 38% of BD Managers your conversations convert into business opportunities.
A broad-spectrum of product portfolios for both In & Out-Licensing conversations. Whether it is “live or digital”, a carefully composed profile-matching mechanism based on key sector-driven criteria allows for efficient and targeted partnering meetings.
A truly international B2B platform: the event offers a partnering opportunity with key players from Europe, Africa, LATAM, CIS, SEA and MENA.
What do our attendees think about PharmaSynergy?
‘Very good overview of the Emerging Markets’
International Marketing and Business Development Manager, Protina Pharmazeutische GMBH (Germany)
This PharmaSynergy edition was exceptional, I have just finished my scheduled meetings, and have lots of excellent leads, creative ideas and relations with wonderful industry colleagues, more than I have expected and had in previous editions.
– SAJA Pharmaceuticals (Saudi Arabia)
'The organization was perfect and enabled participants to enhance their knowledge as well as create the opportunity to have pre-scheduled B2B meetings.’
International Markets Director, Abdi Ibrahim Pharmaceuticals (Turkey)
It was a great event, congratulations! There were fantastic companies attending and very interesting speakers.
– Reig Jofre (Spain)
‘Very good content preparation’
General Manager of China Medical System Holdings (China)